Novartis AG
Novel Pyrazolo Pyrimidine Derivatives

Last updated:

Abstract:

The present invention describes new pyrazolo-pyrimidine derivatives which are generally interacting with MALT1 proteolytic and/or autoproteolytic activity, and in particular which may inhibit said activity. The present invention further describes the synthesis of said new pyrazolo-pyrimidine derivatives, their use as a medicament, especially by interacting with MALT1 proteolytic and/or autoproteolytic activity.

Status:
Application
Type:

Utility

Filling date:

11 Nov 2016

Issue date:

17 Sep 2020